We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Hold Parameters on Likely Cardiovascular Depressant Medications

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00527709
Recruitment Status : Unknown
Verified February 2014 by Hackensack University Medical Center.
Recruitment status was:  Active, not recruiting
First Posted : September 11, 2007
Last Update Posted : February 4, 2014
Information provided by (Responsible Party):

Study Description
Brief Summary:

This pilot study is being pursued to observe whether certain medications are given to patients within a timeframe where their being given could play a part in a critical event in the management of the patient.

There are general rules about when it would be appropriate for these types of medications not to be given. However, it is not current standard practice for the criteria to be put in place without the expressed wishes of the ordering physician or their agent.

Research Question:

Can the administration of cardio-depressant medications be documented as a significant risk factor for hypotensive or bradycardic events?

Condition or disease
Asystole Bradycardia Hypotension

Study Design

Study Type : Observational
Time Perspective: Retrospective
Official Title: Hold Parameters on Likely Cardiovascular Depressant Medications (HOLD)
Study Start Date : August 2006
Estimated Primary Completion Date : August 2006
Groups and Cohorts

Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All

Inclusion Criteria:

  • Serial evaluation of the first 50 documented events of Code Blue or call to Rapid Response Team involving hypotension, bradycardia or asystole in the adult inpatient population events beginning January 1, 2006.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00527709

United States, New Jersey
Hackensack University Medical Center
Hackensack, New Jersey, United States, 07601
Sponsors and Collaborators
Hackensack University Medical Center
Principal Investigator: Amit Tailor, MD, MBA Hackensack University Medical Center
More Information

Responsible Party: Hackensack University Medical Center
ClinicalTrials.gov Identifier: NCT00527709     History of Changes
Other Study ID Numbers: 06.01.025
First Posted: September 11, 2007    Key Record Dates
Last Update Posted: February 4, 2014
Last Verified: February 2014

Additional relevant MeSH terms:
Vascular Diseases
Cardiovascular Diseases
Arrhythmias, Cardiac
Heart Diseases
Pathologic Processes